Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP184129.RAOZJB7Ph8207PPdq5IpqTWxyp6-o97xDayIw3Nack9bo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP184129.RAOZJB7Ph8207PPdq5IpqTWxyp6-o97xDayIw3Nack9bo130_assertion type Assertion NP184129.RAOZJB7Ph8207PPdq5IpqTWxyp6-o97xDayIw3Nack9bo130_head.
- NP184129.RAOZJB7Ph8207PPdq5IpqTWxyp6-o97xDayIw3Nack9bo130_assertion description "[However, the frequency of GSTT1 null genotype was higher among controls (28.7%) than AML cases (21.6%), which showed a protective effect of the null genotype (odds ratioa=a0.58, 95% confidence interval: 0.33-1.05, pa=a0.07).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP184129.RAOZJB7Ph8207PPdq5IpqTWxyp6-o97xDayIw3Nack9bo130_provenance.
- NP184129.RAOZJB7Ph8207PPdq5IpqTWxyp6-o97xDayIw3Nack9bo130_assertion evidence source_evidence_literature NP184129.RAOZJB7Ph8207PPdq5IpqTWxyp6-o97xDayIw3Nack9bo130_provenance.
- NP184129.RAOZJB7Ph8207PPdq5IpqTWxyp6-o97xDayIw3Nack9bo130_assertion SIO_000772 20731606 NP184129.RAOZJB7Ph8207PPdq5IpqTWxyp6-o97xDayIw3Nack9bo130_provenance.
- NP184129.RAOZJB7Ph8207PPdq5IpqTWxyp6-o97xDayIw3Nack9bo130_assertion wasDerivedFrom gad-20150221 NP184129.RAOZJB7Ph8207PPdq5IpqTWxyp6-o97xDayIw3Nack9bo130_provenance.
- NP184129.RAOZJB7Ph8207PPdq5IpqTWxyp6-o97xDayIw3Nack9bo130_assertion wasGeneratedBy ECO_0000203 NP184129.RAOZJB7Ph8207PPdq5IpqTWxyp6-o97xDayIw3Nack9bo130_provenance.